From: Does Losartan reduce the severity of COVID-19 in hypertensive patients?
Variables | Positive PCR | Negative PCR | P value |
---|---|---|---|
Losartan usage | Â | 0.054** | |
yes | 59 | 102 | |
no | 42 | 77 | |
Age (Mean±SD) | 67.45±13.25 | 63.07±13.64 | 0.009* |
LOS (Mean±SD) | 9.02±6.40 | 8.14±6.27 | 0.285* |
Admission status | Â | Â | 0.593** |
In-patient | 176 | 99 | |
Out-patient | 3 | 2 | |
ICU admission | Â | Â | 0.031** |
Yes | 15 | 17 | |
No | 152 | 79 | |
Final outcome | Â | Â | 0.298** |
Alive | 156 | 91 | |
Dead | 23 | 10 | |
Chronic liver disease | Â | Â | 0.639** |
Yes | 0 | 1 | |
No | 101 | 178 | |
DM | Â | Â | 0.473** |
Yes | 39 | 77 | |
No | 62 | 102 | |
CVD | Â | Â | 0.20** |
Yes | 66 | 103 | |
No | 35 | 76 | |
CND | Â | Â | 0.693** |
Yes | 4 | 4 | |
No | 97 | 175 | |
Chronic Lung Disease | Â | Â | 0.027** |
Yes | 15 | 12 | |
No | 86 | 167 | |
CKD | Â | Â | 0.002** |
Yes | 15 | 8 | |
No | 86 | 171 | |
Cancer | Â | Â | 0.681** |
Yes | 1 | 1 | |
No | 100 | 178 |